TheProfitWatch

IMRX - Immuneering Corporation Class A Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
6.98 0.33 (4.73%) 0.01 (0.14%) -0.02 (-0.2%) -0.04 (-0.54%) -0.04 (-0.55%) 0.36 (5.18%) 0.04 (0.59%) 0.07 (1.05%)

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.42
Diluted EPS:
-0.42
Basic P/E:
-17.4048
Diluted P/E:
-17.4048
RSI(14) 1m:
42.86
VWAP:
7.31
RVol:

Events

Period Kind Movement Occurred At

Related News